Health.Market March 29, 2021
We navigate a period of time without much firm guidance awaiting earnings and economic data. When you attend open mic sessions, consider the source. We
We navigate a period of time without much firm guidance awaiting earnings and economic data. When you attend open mic sessions, consider the source. We
A negative week at the headline level without significant technical impact and a lot of internal bullish participation. Market mainly expects strong GDP and earnings
A bullish week in a bullish market. It is healthy to sustain a correction in a dramatically overbought QQQ without crashing the whole market.
The stock market appears to be in a transition from the acute Covid response to a life with Covid where vaccines are impactful and broader
We seem to be in the early stages of the market’s transition from full Covid impact to continuation Covid with vaccines. There was really no
I think the main thing to worry about is whether or not we should be worried. As previously noted either continuation of prior trends or
This week saw an echo continuation of the prior week’s extremely strong bullish move. There were no specific changes in trends except perhaps the VIX
Big tech earnings, fiscal stimulus, vaccines conspired to rally stocks. Tech and SMIDs drove the gains. Stocks + Treasuries + US dollar + commodities +
The market made a rapid reversal that has weakened the short-term upward trend in the indexes. The significance of GME while entertaining is still conjectural.
US equities hit new highs on most of the indexes. Upward momentum is waning and the internal market dynamics are corrective in nature. Biotechnology firms
PO Box 637
Austin, Texas
[email protected]
By providing your contact information you consent to receiving emails & information from Green Room Technologies.
No Spam. We respect your privacy & you may unsubscribe at any time.